Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released Nov 4, 2019, before the open
10-Q filed Nov 4, 2019, 35 days after period end · 0001193125-19-282510
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $13.15M | $239.00K | $0.00 | $48.00K |
| Net Income | -$41.37M | -$48.08M | -$30.64M | -$25.43M |
| EPS Diluted |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.67 |
| -$0.79 |
| -$0.65 |
| -$0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.